Drug
Who makes fosaprepitant?
10 companies list fosaprepitant as a human prescription drug, including under the names NAVITRUX. Forms: injection, powder, lyophilized, for solution. Routes: intravenous.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing fosaprepitant
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Dr. Reddy's Laboratories LimitedIndia | injection, powder, lyophilized, for solution | ANDAANDA209965, ANDA211160 | 3 | 15 |
| BluePoint Laboratories Inc. | injection, powder, lyophilized, for solution | ANDAANDA205020, ANDA209965 | 2 | 0 |
| Novadoz Pharmaceuticals LLC | injection, powder, lyophilized, for solution | ANDAANDA209965 | 2 | 0 |
| Fresenius Kabi USA, LLCUnited States | injection, powder, lyophilized, for solution | ANDAANDA206197 | 1 | 6 |
| Actavis LLCUnited States | injection, powder, lyophilized, for solution | NDANDA210064 | 1 | 1 |
| Avyxa GmbHSwitzerland | injection, powder, lyophilized, for solution | NDANDA220436 | 1 | 1 |
| Bryant Ranch PrepackUnited States | injection, powder, lyophilized, for solution | ANDAANDA209965 | 1 | 1 |
| BE Pharmaceuticals Inc. | injection, powder, lyophilized, for solution | ANDAANDA212309 | 1 | 0 |
| Mylan Institutional Inc. | injection, powder, lyophilized, for solution | ANDAANDA204015 | 1 | 0 |
| Northstar Rx, LLC, | injection, powder, lyophilized, for solution | ANDAANDA209965 | 1 | 0 |
Enquiry
Common questions
- Who makes fosaprepitant?
- 10 companies list fosaprepitant as a human prescription drug in the openFDA NDC Directory, led by Dr. Reddy's Laboratories Limited, BluePoint Laboratories Inc., Novadoz Pharmaceuticals LLC, Fresenius Kabi USA, LLC, Actavis LLC. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic NAVITRUX?
- 8 companies list fosaprepitant under an abbreviated new drug application (ANDA), the application type used for generics, and 2 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.